Yahoo Web Search

Search results

1. • 

     Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs

     Investor's Business Daily· 2 years ago

     Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...

2. • 

     Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris

     Zacks via Yahoo Finance· 2 years ago

     Merck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to...

3. • 

     The secret to breaking down the high price of prescription drugs

     WPXI via Yahoo News· 2 years ago

     An investigation has uncovered the secret to many newer name-brand medications. Some of these...

4. • 

     Pharma CEOs grilled by senators over sky-high drug prices

     NBC News via Yahoo News· 3 months ago

     WASHINGTON — Lawmakers sharply criticized the CEOs of three major drugmakers during a Senate...

5. • Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court

     Reuters via Yahoo Finance· 2 years ago

     A Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...

6. • 

     Important News Update: How To Save on All of Your Prescriptions

     First for Women via Yahoo News· 9 months ago

     On August 29, 2023, the Biden administration unveiled the first 10 drugs that will be subjects of...

7. • 

     Medicare's drug pricing list didn't impact company stocks — here's why

     Yahoo Finance· 9 months ago

     Investor sentiment was indifferent towards the historic announcement Tuesday by the Biden...

8. • 

     Medicare recipients say new drug price negotiations will save them thousands

     ABC News via Yahoo News· 9 months ago

     Every month, Dawn LaGuerre has to decide which bills she's going to pay or if she needs to cut back...

9. • 

     8 Pharma Stocks Affected by New Drug Price Negotiation Rules

     Motley Fool· 9 months ago

     About a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many...

10. • 

      The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List

      Investor's Business Daily· 9 months ago

      There's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...